Shannon Campbell
Board Member
Black Diamond Therapeutics, Inc. (BDTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Shannon Campbell
Shannon Campbell is recorded as Board Member at Black Diamond Therapeutics, Inc. (BDTX). Black Diamond Therapeutics, Inc. reported in an 8-K filed April 11, 2024 that Shannon Campbell was appointed Class III director, effective April 10, 2024.
“On April 10, 2024 (the "Appointment Date"), upon the recommendation of the Nominating and Corporate Governance Committee, the Board appointed (i) Prakash Raman, Ph.D. to serve on the Board as a Class I director to hold office until the Company's annual meeting of stockholders in 2024 or until his earlier death, resignation or removal, and (ii) Shannon Campbell to serve on the Board as a Class III director to hold office until the Company's annual meeting of stockholders in 2026 or until her earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Black Diamond Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Mark A. Velleca CEO
- Mark A. Velleca, M.D., Ph.D. CEO, Chairman
- Mark Velleca CEO
- Mark Velleca, M.D., Ph.D. CEO, Board Member
- Erika Jones CFO, Chief Accounting Officer
- Thomas Leggett CFO
- Brent Hatzis-Schoch COO
- Kapil Dhingra Board Member
- Prakash Raman, Ph.D. Board Member
- Robert A. Ingram Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.